Aveanna price target lowered to $9 from $11 at RBC Capital

RBC Capital lowered the firm’s price target on Aveanna (AVAH) to $9 from $11 and keeps a Sector Perform rating on the shares. Despite solid Q4 results and maintained guidance, shares traded off post-earnings on expectations for moderate rate updates alongside a softer Q4 spread rate, implying potential for weaker margin in 2026, the analyst tells investors in a research note. The moderate rate growth expectations is more illustrative of the success Aveanna has seen in recent years securing rate updates than any indirect Medicaid pressure, RBC added.